Molecular Imaging and Radionuclide Therapy

Scope & Guideline

Advancing breakthroughs in molecular imaging and therapy.

Introduction

Explore the comprehensive scope of Molecular Imaging and Radionuclide Therapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Molecular Imaging and Radionuclide Therapy in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN2146-1414
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2017 to 2024
AbbreviationMOL IMAGING RADIONUC / Mol. Imaging Radionucl. Ther.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The journal 'Molecular Imaging and Radionuclide Therapy' is dedicated to advancing the field of molecular imaging and therapy through innovative research that bridges nuclear medicine, radiology, and oncology. It emphasizes the importance of imaging techniques for diagnosis, treatment planning, and monitoring therapeutic responses in various malignancies and other diseases.
  1. Molecular Imaging Techniques:
    Focuses on the development and application of advanced imaging modalities, such as PET, SPECT, and CT, to visualize biological processes at the molecular and cellular levels.
  2. Radionuclide Therapy:
    Explores the therapeutic applications of radionuclides in treating various cancers, including the mechanisms of action, efficacy, and safety profiles of different radiopharmaceuticals.
  3. Diagnosis and Treatment Monitoring:
    Aims to improve diagnostic accuracy and treatment outcomes through imaging techniques that allow for the evaluation of treatment responses and the identification of disease recurrence.
  4. Clinical Applications in Oncology:
    Highlights the role of molecular imaging in oncology, particularly in the detection, characterization, and staging of tumors, as well as in personalized treatment approaches.
  5. Interdisciplinary Research:
    Encourages collaboration between researchers, clinicians, and industry to foster innovations in imaging and therapy, combining insights from nuclear medicine, radiology, and pathology.
The landscape of research in 'Molecular Imaging and Radionuclide Therapy' is evolving, with several emerging themes reflecting current trends in the field. These themes indicate areas of heightened interest and potential growth.
  1. Novel Radiopharmaceuticals:
    A growing body of research is focusing on the development and clinical application of novel radiopharmaceuticals, particularly those targeting specific molecular markers in cancers.
  2. Theranostics:
    The integration of therapeutic and diagnostic approaches, known as theranostics, is increasingly prevalent, allowing for personalized treatment strategies based on imaging findings.
  3. Artificial Intelligence in Imaging:
    The application of artificial intelligence and machine learning techniques for image analysis and interpretation is emerging as a significant trend, enhancing diagnostic accuracy and workflow efficiency.
  4. Immuno-PET Imaging:
    Research on immuno-PET, which combines immunotherapy with PET imaging to monitor treatment response, is gaining traction as a promising area for personalized cancer management.
  5. Radiomics and Texture Analysis:
    The use of radiomics to extract quantitative features from imaging data for predicting treatment outcomes and tumor characteristics is increasingly popular, reflecting the trend towards data-driven approaches in oncology.

Declining or Waning

While the journal maintains a strong focus on cutting-edge research, certain themes have seen a decline in prominence over recent years. This section identifies these waning scopes, reflecting shifts in research interests and advancements in technology.
  1. Non-Oncological Applications:
    Research focusing on non-oncological applications of molecular imaging and radionuclide therapy has decreased, as the field has increasingly concentrated on oncology-related studies.
  2. Older Imaging Techniques:
    There is a noticeable decline in publications centered around older imaging techniques that have been largely supplanted by more advanced methodologies, such as PET/CT and hybrid imaging.
  3. Basic Science Studies:
    The journal has shifted towards more clinically oriented research, resulting in fewer publications that focus solely on the basic science aspects of imaging and therapy.
  4. Traditional Radiopharmaceuticals:
    Research on traditional radiopharmaceuticals that do not incorporate newer imaging technologies or innovative therapeutic approaches is becoming less frequent.

Similar Journals

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN

Illuminating Innovations in Imaging and Therapy
Publisher: GEORG THIEME VERLAG KGISSN: 1438-9029Frequency: 12 issues/year

ROFO-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, published by Georg Thieme Verlag KG, is a pivotal journal in the fields of radiology and nuclear medicine, offering invaluable insights for researchers, healthcare professionals, and students alike. With an ISSN of 1438-9029, this journal has been a stalwart of scientific communication since its inception in 1975, actively contributing to advancements in imaging techniques and radiation therapy. Although it operates under traditional access, the journal maintains a respectable standing, reflected by its Q3 ranking in Radiology, Nuclear Medicine and Imaging and Q4 in Medicine (miscellaneous), highlighting its significance in the scholarly community. Its coverage spans a wide array of topics pertinent to diagnostic imaging and therapy protocols, making it an essential resource for anyone seeking to understand the complexities of modern radiological practices. As the journal continues to evolve through 2024, it invites contributions that enrich the dialogue around technological innovations and clinical applications in the realm of imaging modalities.

NUCLEAR MEDICINE COMMUNICATIONS

Connecting Researchers to Revolutionize Patient Outcomes
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0143-3636Frequency: 12 issues/year

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

BRITISH JOURNAL OF RADIOLOGY

Transforming Clinical Insights with Cutting-Edge Research
Publisher: BRITISH INST RADIOLOGYISSN: 0007-1285Frequency: 12 issues/year

British Journal of Radiology is a leading peer-reviewed journal published by the British Institute of Radiology, dedicated to advancing the field of radiology, nuclear medicine, and imaging. With a prestigious history dating back to 1945, this journal is at the forefront of disseminating cutting-edge research and innovations that significantly impact clinical practice. Currently enjoying a Q1 ranking in the field of radiology and Q2 in general medicine for 2023, it is recognized for its rigorous standards and high-quality content, ranking #87 out of 333 in Scopus for specialties related to Medicine, Radiology, Nuclear Medicine, and Imaging, placing it in the 74th percentile. Researchers, professionals, and students are encouraged to engage with the latest findings and comprehensive reviews presented within its pages, which contribute not only to academic discourse but also to the evolution of practice in the wider medical community.

Japanese Journal of Radiology

Connecting Researchers and Practitioners in Radiology
Publisher: SPRINGERISSN: 1867-1071Frequency: 10 issues/year

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

Revista Espanola de Medicina Nuclear e Imagen Molecular

Advancing the Frontiers of Nuclear Medicine and Molecular Imaging
Publisher: ELSEVIER ESPANA SLUISSN: 2253-654XFrequency: 6 issues/year

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.

BMC MEDICAL IMAGING

Advancing the Future of Radiology and Imaging Technologies.
Publisher: BMCISSN: 1471-2342Frequency: 1 issue/year

BMC Medical Imaging is a premier open-access journal dedicated to advancing the field of radiology, nuclear medicine, and imaging technologies. Published by BMC in the United Kingdom, this journal serves as a vital resource for researchers, clinicians, and students, fostering a collaborative environment for sharing innovative findings and methodologies in medical imaging. With a commendable impact factor and an impressive Scopus ranking within the top 35% of its category, BMC Medical Imaging provides a platform for high-quality research to be disseminated widely and freely since its inception in 2001. The journal aims to cover a diverse array of topics, from advanced imaging techniques to their clinical applications, enhancing the understanding and effectiveness of diagnostic practices. By contributing to the body of knowledge and facilitating open access to research, BMC Medical Imaging plays a pivotal role in shaping the future of medical imaging and improving patient care.

Molecular Imaging

Connecting Science and Imaging for a Healthier Tomorrow.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.

Tomography

Pioneering advancements in tomography and diagnostics.
Publisher: MDPIISSN: 2379-1381Frequency: 6 issues/year

Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.

NUKLEARMEDIZIN-NUCLEAR MEDICINE

Elevating Standards in Radiology and Imaging Practices.
Publisher: GEORG THIEME VERLAG KGISSN: 0029-5566Frequency: 6 issues/year

NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.

CANCER IMAGING

Advancing the Frontiers of Cancer Diagnostics
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.